Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapeutics symbols : Snynf save search
Curio Digital Therapeutics Inc. Announces the U.S. Food and Drug Administration (FDA) Clearance of MamaLift Plus™, the First Prescription Digital Therapeutic Authorized for the Treatment of Postpartum Depression (PPD)
Published: 2024-04-23 (Crawled : 00:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.7%
H: 0.0%
C: 0.0%
first drug authorized food depression treatment clearance for therapeutics
Over-The-Counter Drug Market size is set to grow by USD 58.54 billion from 2023-2027, Abbott Laboratories, Achelios Therapeutics Inc. and AstraZeneca Plc, and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-04-22 (Crawled : 22:00) - prnewswire.com
RBGPF | News | $52.06 6.46% 4.8K
|
Consumer Non-Durables
|
| O: 0.98%
H: 5.46%
C: -0.89%
GLAXF | News | $19.54 -3.77% -14.18% 2.6K
|
Health Technology
|
| O: -3.15%
H: 0.0%
C: -0.61%
AZNCF | News | $140.3 1.13% -4.19% 1.5K
|
Health Technology
|
| O: 0.96%
H: 2.38%
C: 0.17%
NVSEF | News | $96.0 0.94% 6.88% 52K
|
Health Technology
|
| O: 1.69%
H: 0.02%
C: -0.74%
RBGLY | News | $10.59 -2.05% 850K
|
Manufacturing
|
| O: -0.28%
H: 2.18%
C: 1.99%
NVS | News | $97.28 2.27% 1.21% 3.5M
|
Health Technology
|
| O: 4.32%
H: 0.0%
C: 0.0%
GSK | News | $41.24 1.6% -0.58% 2.1M
|
Health Technology
|
| O: 0.17%
H: 1.48%
C: 1.43%
ABT | News | $107.59 0.49% 0.4% 3.1M
|
Health Technology
|
| O: 0.56%
H: 0.41%
C: -0.07%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.7%
H: 0.0%
C: 0.0%
AZN | News | $70.85 1.03% 1.02% 4.9M
|
Health Technology
|
| O: 0.4%
H: 0.0%
C: 0.0%
drug astrazeneca set key therapeutics market
BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn
Published: 2024-04-16 (Crawled : 23:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.12%
H: 0.51%
C: 0.51%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.05%
H: 0.0%
C: 0.0%
management company cell nurown trial therapeutics
Biologic Therapeutics Market size is set to grow by USD 286.12 billion from 2023-2027, Introduction of biosimilars boost the market, Technavio
Published: 2024-04-15 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.75%
H: 0.85%
C: 0.85%
AZNCF | News | $140.3 1.13% -4.19% 1.5K
|
Health Technology
|
| O: 2.1%
H: 0.0%
C: -2.52%
NVS | News | $97.28 2.27% 1.21% 3.5M
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: 0.0%
GSK | News | $41.24 1.6% -0.58% 2.1M
|
Health Technology
|
| O: -1.19%
H: 0.52%
C: -0.17%
BAX | $41.02 1.54% 0.8% 2.6M
|
Health Technology
|
| O: -0.1%
H: 0.13%
C: -1.08%
ABBV | News | $169.54 0.98% 0.18% 3.2M
|
Health Technology
|
| O: 0.32%
H: 0.96%
C: 0.22%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -2.13%
H: 0.0%
C: 0.0%
BMRN | $92.06 2.87% 2.79% 1.3M
|
Health Technology
|
| O: -0.72%
H: 0.0%
C: 0.0%
AZN | News | $70.85 1.03% 1.02% 4.9M
|
Health Technology
|
| O: -0.64%
H: 0.45%
C: -0.04%
AMGN | News | $273.54 0.6% 0.65% 1.9M
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
set therapeutics market
Gastrointestinal Therapeutics and Diagnostics: Propelling Global Markets with Cutting-Edge Technologies by BCC Research LLC
Published: 2024-04-15 (Crawled : 11:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.53%
H: 0.61%
C: 0.61%
JNJ | News | $149.56 0.3% -0.17% 6.9M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
ABBV | News | $169.54 0.98% 0.18% 3.2M
|
Health Technology
|
| O: 0.13%
H: 0.11%
C: -1.73%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.95%
H: 0.0%
C: 0.0%
research global gastrointestinal therapeutics
Orna Therapeutics Appoints Frank Neumann, M.D., Ph.D., as Chief Medical Officer
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
VSTM | $9.58 -1.64% -1.67% 100K
|
Health Technology
|
| O: -0.4%
H: 4.84%
C: 4.79%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
medical therapeutics
Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update
Published: 2024-04-10 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
NRIX 6 d | $14.13 4.05% 3.86% 900K
|
Health Technology
|
| O: 18.35%
H: 1.98%
C: -5.88%
first update therapeutics financial results
Nurix Therapeutics Announces Extension of Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degraders of STAT6
Published: 2024-04-09 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.38%
H: 0.95%
C: 0.83%
NRIX 6 d | $14.13 4.05% 3.86% 900K
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
protein collaboration extension therapeutics sanofi
Eczema Therapeutics Market size is set to grow by USD 5.81 bn from 2024-2028,high prevalence of atopic dermatitis boost the market- Technavio
Published: 2024-04-08 (Crawled : 18:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 2.24%
H: 0.0%
C: -0.8%
AZNCF | News | $140.3 1.13% -4.19% 1.5K
|
Health Technology
|
| O: -3.43%
H: 6.21%
C: 6.21%
VTRS | News A | $11.36 0.98% 0.97% 4.7M
|
Health Technology
|
| O: -0.25%
H: 1.1%
C: -0.17%
NVS | News | $97.28 2.27% 1.21% 3.5M
|
Health Technology
|
| O: -0.05%
H: 0.43%
C: -0.27%
BMY | $48.99 -0.31% 0.84% 7.1M
|
Health Technology
|
| O: -0.08%
H: 0.04%
C: -0.35%
BHC | $8.53 0.95% 0.0% 4M
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: -7.27%
ABBV | News | $169.54 0.98% 0.18% 3.2M
|
Health Technology
|
| O: 0.77%
H: 1.63%
C: 0.35%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.84%
H: 0.0%
C: 0.0%
AZN | News | $70.85 1.03% 1.02% 4.9M
|
Health Technology
|
| O: 0.18%
H: 0.3%
C: 0.19%
eczema dermatitis set therapeutics market
OMass Therapeutics expands Scientific Advisory Board with the appointment of Sarah Teichmann
Published: 2024-04-08 (Crawled : 09:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 2.24%
H: 0.0%
C: -0.8%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.84%
H: 0.0%
C: 0.0%
therapeutics
Odyssey Therapeutics Appoints Julie Clauss as Chief Operating Officer and Christopher Butler as SVP, Head of Chemistry
Published: 2024-04-02 (Crawled : 14:30) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -1.14%
H: 0.02%
C: -1.06%
therapeutics
Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published: 2024-03-29 (Crawled : 18:00) - prnewswire.com
BMY | $48.99 -0.31% 0.84% 7.1M
|
Health Technology
| Email alert
Add to watchlist
GILD | $67.03 0.12% 0.12% 3.6M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
AMGN | News | $273.54 0.6% 0.65% 1.9M
|
Health Technology
| Email alert
Add to watchlist
GMAB | News | $28.56 -1.42% -1.51% 530K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $96.0 0.94% 6.88% 52K
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $97.28 2.27% 1.21% 3.5M
|
Health Technology
| Email alert
Add to watchlist
GNMSF | News | $290.34 0.23% 3.83% 340
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $169.54 0.98% 0.18% 3.2M
|
Health Technology
| Email alert
Add to watchlist
research global leukemia therapeutics market
Dyne Therapeutics Announces CEO Transition
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.42%
H: 0.0%
C: 0.0%
DYN | $25.44 2.29% 2.24% 810K
|
Health Technology
|
| O: -13.24%
H: 11.02%
C: 6.37%
BIIB | $193.18 -0.48% -0.48% 1.2M
|
Health Technology
|
| O: -0.15%
H: 0.23%
C: -0.5%
ceo therapeutics
Mirador Therapeutics Launches to Accelerate the Next Generation of Precision Medicines for Immune-mediated Diseases
Published: 2024-03-21 (Crawled : 12:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.14%
H: 0.24%
C: 0.24%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
precision therapeutics
CytomX Therapeutics Appoints Dr. Zhen Su to Board of Directors
Published: 2024-03-21 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.14%
H: 0.24%
C: 0.24%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
CTMX | $1.68 0.6% 0.6% 290K
|
Health Technology
|
| O: -1.76%
H: 3.59%
C: 0.45%
therapeutics
Monoclonal Antibody (mABs) Therapeutics Market Worth $497.5 billion | MarketsandMarkets™
Published: 2024-03-15 (Crawled : 14:30) - prnewswire.com
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: 0.21%
H: 0.97%
C: 0.7%
NVS | News | $97.28 2.27% 1.21% 3.5M
|
Health Technology
|
| O: 0.05%
H: 0.14%
C: -0.93%
JNJ | News | $149.56 0.3% -0.17% 6.9M
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
LLY | News | $745.69 1.96% 0.04% 1.4M
|
Health Technology
|
| O: -0.7%
H: 0.73%
C: -0.16%
ABBV | News | $169.54 0.98% 0.18% 3.2M
|
Health Technology
|
| O: -0.07%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
REGN | News | $906.84 0.74% 0.74% 340K
|
Health Technology
|
| O: -0.27%
H: 1.26%
C: 0.84%
AMGN | News | $273.54 0.6% 0.65% 1.9M
|
Health Technology
|
| O: 0.2%
H: 1.14%
C: -1.18%
antibody therapeutics market
Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-13 (Crawled : 13:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
SGMO | News | $0.5212 2.18% 2.13% 2.3M
|
Health Technology
|
| O: 2.19%
H: 4.55%
C: -10.78%
business year therapeutics financial results
AnHeart Therapeutics and Innovent Announce China’s NMPA has Accepted Second New Drug Application for Taletrectinib for First-Line Treatment of ROS1-Positive Lung Cancer
Published: 2024-03-05 (Crawled : 08:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.17%
H: 0.0%
C: 0.0%
lung drug cancer treatment application therapeutics
Innovent and AnHeart Therapeutics Announce the NMPA of China Has Accepted Second NDA for Taletrectinib for First-Line Treatment of ROS1-Positive Lung Cancer
Published: 2024-03-05 (Crawled : 06:00) - prnewswire.com
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.17%
H: 0.0%
C: 0.0%
INCY | $51.65 -0.52% -0.58% 2.5M
|
Health Technology
|
| O: 0.4%
H: 0.38%
C: -1.77%
lung cancer treatment therapeutics china
Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Published: 2024-02-27 (Crawled : 13:00) - globenewswire.com
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.94%
H: 0.0%
C: 0.0%
DNLI | $16.11 0.75% 0.74% 1.1M
|
Health Technology
|
| O: 18.06%
H: 17.95%
C: 17.1%
business year therapeutics financial results
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 26M
|
AGBA | $2.97 137.6% 57.48% 66M
|
Finance
EDBL | News | $6.59 75.27% 41.8% 2M
|
MTC | $2.24 43.59% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.33 30.39% 24.16% 390K
|
Technology Services
ABVC | $1.35 29.81% 23.53% 7.1M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.